**Updated July 1, 2021**

U.S. Forces Japan extends Japan-wide public health emergency

The commander of US Forces Japan has extended the Public Health Emergency (PHE) for Japan in accordance with DoD Instruction (DoDI) 6200.03, “Public Health Emergency Management (PHEM) Within the DoD.” The PHE will automatically terminate on 27 September 2021, unless it is renewed and republished or sooner terminated by the commander. This order supersedes the previous PHE declaration for Japan issued on 8 March 2020.

  • Prohibited non-essential services and activities within any prefecture in Japan include bars, night clubs, karaoke clubs, social clubs, or any facility with a potential for crowds, close contact, or closed spaces where COVID prevention measures cannot be maintained.

CDC - www.cdc.gov

USFJ Facebook - https://www.facebook.com/USForcesJapan/

Foreign Clearance Guide (CAC Enabled) - https://apacs.milcloud.mil/apacs/ssoservlet

Yokota Passenger Terminal Facebook - https://www.facebook.com/YokotaPassengerterminal730ams/

DoD COVID Guidance - https://www.defense.gov/Explore/Spotlight/Coronavirus/Latest-DOD-Guidance/

Force Health Protection & Fragmentary Orders Archive - https://www.usfj.mil/US-Forces-Japan-COVID-19/PHE-FRAGO-Archive/


COVID-19 Vaccine Distribution

** To schedule a COVID-19 vaccination appointment, visit the 374th Medical Group appointment page at: https://yokota.tricare.mil/Getting-Care/Appointments-Referrals/

U.S. Forces Japan (USFJ) is implementing the Department of Defense (DoD) COVID-19 vaccine plan centered on a standardized and coordinated strategy for prioritizing, distributing, and administering the COVID-19 vaccine. 

USFJ has implemented the DoD’s phased approach to vaccinate all Active component, Reserve component, TRICARE Prime and TRICARE Select beneficiaries, and select DoD civilians and contract personnel along with Local National employees that are not contractors authorized to receive immunizations from DoD. Please see above link to schedule an appointment to receive a vaccine.

Questions and Answers